Predictive Capabilities BioModels specializes in predictive and highly translational efficacy studies for biotech and pharma, indicating strong potential for consultative CRO partnerships that expand animal model offerings and study design services.

Microbiome Initiative The TBMI collaboration with Taconic Biosciences opens a gateway for microbiome-focused preclinical programs, presenting a cross-sell opportunity to clients pursuing germ-free and gnotobiotic study designs.

Advanced Imaging Investments in HD video endoscopy, IVIS imaging, and pulmonary function assessment (FlexiVent) position BioModels to upsell high-resolution, non-invasive in vivo data packages for oncology, respiratory, and metabolism programs.

Global Access With a capable facility and strategic partnerships, BioModels can pitch expanded project scope and multi-site studies to sponsors seeking robust translational models and streamlined data integration across platforms.

Market Positioning Operating as an AAALAC-accredited preclinical CRO with a decade of experience, BioModels can approach mid-size biotech firms and early-stage pharma customers looking for personalized service and proven study design to de-risk translational risk.